Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome
Conditions: Obstructive Sleep Apnea; Down Syndrome Intervention: Drug: Atomoxetine and Oxybutynin (ato-oxy) Sponsors: University of Arizona; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Children | Down's Syndrome | Heart | Obstructive Sleep Apnea | Research | Sleep Apnea | Sleep Disorders | Sleep Medicine